Evaluating the regulatory function of non-coding autism-associated single nucleotide polymorphisms on gene expression...

Area of Science:

• Genetics
• Neuroscience
• Bioinformatics

Background:

• Common genetic variants explain much of the heritability of autism spectrum disorder (ASD).
• Genome-wide association studies (GWAS) have identified numerous single nucleotide polymorphisms (SNPs) associated with ASD, but their functional roles are unclear.
• These identified SNPs are located in non-coding genomic regions, suggesting regulatory functions rather than direct effects on gene coding.

Purpose of the Study:

• To functionally annotate ASD-associated polymorphisms and their linkage disequilibrium partners using a comprehensive bioinformatics pipeline.
• To identify potential regulatory DNA variants contributing to autism pathogenesis.
• To experimentally validate the predicted regulatory effects of candidate variants on gene expression in human brain tissue.

Main Methods:

• Applied a bioinformatics pipeline to annotate ASD-associated SNPs and their non-coding linkage disequilibrium partners.
• Identified 82 candidate DNA variants with probable regulatory functions.
• Measured the impact of 11 high-confidence candidate variants and their partners on gene expression in post-mortem human brain tissue from autistic and non-autistic donors using quantitative polymerase chain reaction (qPCR).

Main Results:

• Identified 82 potential regulatory DNA variants associated with autism.
• A small number of variants showed a measurable impact on gene expression, but these findings did not withstand correction for multiple comparisons.
• No significant genotype-by-diagnosis interactions were observed for the studied SNP-gene associations.

Conclusions:

• The study identified numerous potential regulatory variants linked to autism, but experimental validation in human brain tissue yielded limited significant results.
• The modest impact of individual variants on gene expression may be difficult to detect in post-mortem brain samples.
• Limitations in current GWAS data and the complexity of neurodevelopmental disorders may hinder the identification of functional genetic contributions to autism.